Term: glycinamide ribonucleotide formyltransferase inhibitor Pronunciation: (gly-SIH-nuh-mide RY-boh-NOO-klee-oh-tide FOR-mil-TRANZ-feh-rays in-HIH-bih-ter) May 24, 2024October 7, 2025 Description: A drug that blocks DNA synthesis and may prevent tumor growth. It is being studied as a treatment for cancer. Related Posts:Pacritinib for Myelofibrosis - A New JAK-2 Inhibitor…FDA Approves ALIQOPA®, a PI3K Inhibitor, for…FDA Approves ALIQOPA®, a PI3K Inhibitor, for…FDA Approves First PI3K Inhibitor, PIQRAY®, for…LAG-3 Inhibitor Relatlimab and OPVIDO® in Advanced…FDA Approves BCL2 Inhibitor VENCLEXTA® for Chronic…